Overview

Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy

Status:
NOT_YET_RECRUITING

Trial end date:
2026-07-01

Target enrollment:

Participant gender:

Summary

The investigators are doing this study to discover if it is appropriate for people with Cystic Fibrosis (CF) on highly effective modulator therapy (HEMT) to stop using certain standard Sino nasal therapies such as high-volume nasal saline irrigations, topical nasal steroids, and topical nasal antibiotics. They are also going to study the fluid inside the nose to see if there are changes when stopping these therapies. Right now, they are not sure if it is suggested to stop these treatments when patients begin highly effective modulator therapy (HEMT)

Phase:

PHASE3

Details

Lead Sponsor:

Indiana University

Collaborator:

American Rhinologic Society

Treatments:

Patient Health Questionnaire
Respiratory Function Tests
Steroids